Viridian Therapeutics is a startup based in the United States, 1 tracked investor.
Viridian Therapeutics is a startup based in the United States. Brouky records 1 investor associated with the company.
Viridian Therapeutics develops optimized antibody-based treatments targeting rare autoimmune diseases, including programs focused on Thyroid Eye Disease and FcRn pathways.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.